SUDA Pharmaceuticals: European Anagrelide Cancer Patent
Monday, July 22, 2019 | DrugName : anagrelide SUDA Pharmaceuticals Ltd, a leader in oro-mucosal drug delivery, is pleased to
Read More
Monday, July 22, 2019 | DrugName : anagrelide SUDA Pharmaceuticals Ltd, a leader in oro-mucosal drug delivery, is pleased to
Read MoreFriday, June 20, 2019 Florence announced assignment of U.S. Patent No. 10,319,479 by the United States Patent and Trademark Office
Read MoreFriday, July 19, 2019 The U.S. Patent and Trademark Office (USPTO) has awarded a new patent to the University of
Read MoreTuesday, July 16, 2019 Artificial intelligence (AI) drug discovery firm Recursion Pharmaceuticals, has secured $121m in a series C funding
Read MoreThursday, July 18, 2019 | Merck, a leading science and technology company, and the Broad Institute of MIT and Harvard announced
Read More